Streetbeat News

Insider Trading

AYI

BOX

NTAP

QCOM

Insiders at Qualcomm, NetApp, Box, and Acuity Brands have recently sold shares of their companies. Qualcomm's CCO sold 1,000 shares, NetApp's CFO sold 15,000 shares, Box's CFO and Controller sold a combined 20,750 shares, and Acuity Brands' SVP & General Counsel sold 1,900 shares. These sales occurred amidst various company-specific news such as product announcements, analyst ratings, and financial results.

Portfolio Pulse from Avi Kapoor

January 12, 2024 | 1:49 pm

ENTX

FRTX

OPK

VGZ

Insiders at four companies have recently made notable purchases of their own company's stock. Entera Bio Ltd. (ENTX) Director Haya Taitel bought shares at $0.77 each after the company received an extension from Nasdaq to regain compliance. OPKO Health, Inc. (OPK) 10% owner Frost Gamma Investments Trust purchased shares at $0.94 each following the pricing of a $200 million convertible notes offering. Fresh Tracks Therapeutics, Inc. (FRTX) 10% owner Exploration Capital LLC acquired shares at $0.98 each as the company plans a special meeting to seek approval of liquidation. Vista Gold Corp. (VGZ) Director Tracy Austin Stevenson bought shares at $0.37 each after the company announced a $20 million royalty agreement with Wheaton Precious Metals.

Portfolio Pulse from Avi Kapoor

January 12, 2024 | 12:48 pm

ADC

DYN

EYPT

Insider purchases at Dyne Therapeutics, EyePoint Pharmaceuticals, and Agree Realty indicate confidence in these companies. Dyne Therapeutics' 10% owner Dirk Kersten acquired shares worth $30M following a $300M public stock offering. EyePoint Pharmaceuticals' 10% owner bought shares for $17.05M, and Agree Realty's Director purchased shares worth approximately $657K. Insider trading can signal investment opportunities but should not be the sole decision factor.

Portfolio Pulse from Avi Kapoor

January 12, 2024 | 11:38 am

EYPT

Cormorant Global Healthcare Master Fund, LP has acquired 855,000 shares of EyePoint Pharmaceuticals, as indicated by a Form 4 filing.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 9:09 pm

SCHW

Arkansas Representative French Hill sold Charles Schwab (NYSE:SCHW) stock valued between $50,001 and $100,000 on January 10, 2024. The sale was reported in a Periodic Transaction Report. While Congressional transactions can be a consideration for investors, they are not a primary factor for investment decisions. The STOCK Act prohibits Congress members from using non-public information for personal gain in stock transactions.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 3:05 pm

CMXC

LPSN

OPK

Insiders at OPKO Health, LivePerson, and Cell MedX have made significant stock purchases. OPKO Health's Chief Innovation Officer acquired shares worth around $200,427. LivePerson's 10% owner bought shares for approximately $6.29 million, and Cell MedX's CEO purchased shares valued at about $622,718. These transactions may signal insider confidence in the companies' prospects. OPKO Health recently priced a $200 million convertible notes offering, LivePerson appointed a new CEO, and Cell MedX settled a significant debt with shares.

Portfolio Pulse from Avi Kapoor

January 11, 2024 | 1:39 pm

VTAK

Catheter Precision, Inc. (NYSE:VTAK) CEO and Chairman, David Jenkins, is authorized to buy up to 500,000 shares of VTAK common stock in the open market. This decision reflects his confidence in the company's future and ongoing development of medical technologies like the LockeT product and VIVO 3D mapping system. Jenkins' purchase decision will depend on various factors, including VTAK's stock price and his capital needs. There's no guarantee that all authorized shares will be bought, and purchases will comply with legal and NYSE American rules.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:07 pm

AXNX

HOOD

PANW

UPST

Insiders at Axonics, Upstart Holdings, Palo Alto Networks, and Robinhood Markets have recently sold shares of their companies. Axonics is being acquired by Boston Scientific, while Upstart reported disappointing Q3 results. Citigroup raised the price target for Palo Alto Networks, and Keybanc increased the price target for Robinhood. Insider sales can be part of preplanned strategies or may reflect personal views on the company's valuation.

Portfolio Pulse from Avi Kapoor

January 11, 2024 | 12:46 pm

CDMO

KALV

SCWX

STAA

Insiders at STAAR Surgical, KalVista Pharmaceuticals, Avid Bioservices, and SecureWorks have recently made significant stock purchases. STAAR Surgical's 10% owner bought shares after the company issued positive sales guidance. KalVista's 10% owner and Chief Scientific Officer engaged in stock transactions following the publication of research data. Avid Bioservices' director made a purchase despite the company reporting disappointing financial results and lowering revenue guidance. SecureWorks' 10% owner increased his stake after the company reported strong sales.

Portfolio Pulse from Avi Kapoor

January 11, 2024 | 11:40 am

BABA

U.S. Rep. Laurel Lee and her husband sold $100,000 to $250,000 in Alibaba Group Holding (NYSE:BABA) shares, drawing scrutiny due to her critical stance on China and her position on a Homeland Security subcommittee. The trade was disclosed on Quiver Quant's Congress trading dashboard and has been highlighted by social media influencers. Lee has previously denied allegations of her family's ties to the Chinese Communist Party, stating the stocks are owned by her husband and not a marital asset.

Portfolio Pulse from Chris Katje

January 10, 2024 | 5:37 pm